Safety and Cardiovascular Efficacy of Spironolactone in Dialysis-Dependent ESRD Trial

NCT02285920 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

129

Enrollment

OTHER

Sponsor class

Conditions

End-Stage Renal Disease

Interventions

DRUG: Spironolactone

Sponsor

University of Pennsylvania

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]